See All Slides - tctmd.com

Slides

Presentation The Structural Heart Disease Summit 2018

NO: The Data Are Weak and the Costs Are Prohibitive!

Presenter: John K. Forrest

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Presenter: Vinayak Bapat, Ran Kornowski, Philipp Blanke

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Is Paravalvular Regurgitation After TAVR Still an Important Consideration in 2018?

Presenter: Philippe Pibarot

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Urgent Transcatheter Aortic Valve Replacement for Severe Acute Aortic Regurgitation Following Open Mitral Valve Surgery

Presenter: Ashish Pershad, Roberto Spina, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

YES: Review of ALL the Data and Common Sense Tell the Story!

Presenter: Axel Linke

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Case #3: A Small (Undersized) Surgical Bioprosthesis

Presenter: Michael J. Reardon, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

An Introduction to the WATCH-TAVR Trial Combining TAVR and LAAC

Presenter: Amar Krishnaswamy

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Transcaval TAVR Complicated by Double Wammy

Presenter: Ashish Pershad, Waleed Alharbi, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Case #2: A Stentless (or Stented With Leaflets Outside the Stent) Surgical Bioprosthesis

Presenter: Brian K. Whisenant, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

European Perspectives and Updates From a Randomized Trial Combining TAVR and LAAC

Presenter: Fabian Nietlispach

June 21, 2018

Advertisement

Slides

NO: The Data Are Weak and the Costs Are Prohibitive!

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Is Paravalvular Regurgitation After TAVR Still an Important Consideration in 2018?

Urgent Transcatheter Aortic Valve Replacement for Severe Acute Aortic Regurgitation Following Open Mitral Valve Surgery

YES: Review of ALL the Data and Common Sense Tell the Story!

Case #3: A Small (Undersized) Surgical Bioprosthesis

An Introduction to the WATCH-TAVR Trial Combining TAVR and LAAC

Transcaval TAVR Complicated by Double Wammy

Case #2: A Stentless (or Stented With Leaflets Outside the Stent) Surgical Bioprosthesis

European Perspectives and Updates From a Randomized Trial Combining TAVR and LAAC

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content